Skip to content

Clinical trials

Completed Phase 1 Substance-Related Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Substance-Related Disorders Phase: Phase 1 Status: Completed Clear all

131 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20032
20048
20053
20065
20078
200813
200912
201012
201110
20129
20136
20143
20151
20164
20175
20182
20192
20203
20213
20221
20232
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed131

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute on Drug Abuse (NIDA)15
Baylor College of Medicine12
GlaxoSmithKline10
University Hospital, Basel, Switzerland8
Brown University4
Oregon Research Institute4
Yale University4
Medical University of South Carolina3
University of Washington3
Dartmouth-Hitchcock Medical Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Substance-Related Disorders131
Cocaine-Related Disorders12
Alcoholism11
Opioid-Related Disorders10
Mental Disorders7
Mood Disorders6
Amphetamine-Related Disorders5
HIV Infections5
Alcohol-Related Disorders4
Anxiety Disorders4

Trials

Showing 1 to 25 of 131. Each trial links to its page on Pharma Observatory.

31 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.